Table 1.
Characteristic | All Patients (N = 1,200) |
Insurance Type |
||||||
---|---|---|---|---|---|---|---|---|
Medicare With Private Insurance (n = 549) |
Medicare Only (n = 304) |
Medicare and Medicaid (n = 347) |
||||||
No. | %* | No. | %* | No. | %* | No. | %* | |
Age group, years | ||||||||
65-69 | 283 | 21.5 | 138 | 24.5 | 62 | 11.9 | 83 | 26.2 |
70-74 | 303 | 25.3 | 133 | 25.9 | 72 | 24.1 | 98 | 25.5 |
75-79 | 284 | 24.8 | 122 | 21.7 | 84 | 33.4 | 78 | 22.0 |
80-84 | 195 | 17.8 | 100 | 18.3 | 44 | 16.9 | 51 | 17.5 |
≥ 85 | 135 | 10.6 | 56 | 9.6 | 42 | 13.7 | 37 | 8.8 |
Race | ||||||||
Non-Hispanic white | 578 | 80.3 | 357 | 90.2 | 165 | 82.1 | 56 | 44.1 |
Non-Hispanic black | 269 | 9.1 | 94 | 5.4 | 71 | 8.7 | 104 | 22.2 |
Hispanic | 161 | 4.6 | 49 | 1.9 | 37 | 4.5 | 75 | 14.1 |
Asian/Pacific Islander | 181 | 5.9 | 45 | 2.4 | 29 | 4.6 | 107 | 19.5 |
American Indian† | 11 | 0.1 | < 11 | — | < 11 | — | < 11 | — |
Marital status | ||||||||
Married | 577 | 51.2 | 303 | 58.8 | 146 | 44.1 | 128 | 36.8 |
Unmarried | 623 | 48.8 | 246 | 41.2 | 158 | 55.9 | 219 | 63.2 |
Cancer site and stage | ||||||||
Breast IIB-III | 120 | 19.4 | 62 | 23.0 | 23 | 12.2 | 35 | 18.5 |
Colon III | 234 | 12.2 | 108 | 11.6 | 59 | 14.4 | 67 | 10.8 |
Rectal II-III | 301 | 17.7 | 124 | 15.7 | 89 | 22.1 | 88 | 17.3 |
NSCLC II-IV | 288 | 45.2 | 125 | 43.9 | 60 | 45.9 | 103 | 48.8 |
Ovarian II-IV | 257 | 5.5 | 130 | 5.8 | 73 | 5.5 | 54 | 4.6 |
Charlson comorbidity score | ||||||||
0 | 772 | 59.2 | 360 | 59.1 | 205 | 62.9 | 360 | 59.1 |
1 | 313 | 29.3 | 139 | 29.1 | 72 | 26.2 | 139 | 29.1 |
≥ 2 | 115 | 11.6 | 50 | 11.8 | 27 | 11.0 | 50 | 11.8 |
Prediagnosis physician visit in nursing home | ||||||||
No | 1,156 | 96.3 | 542 | 98.5 | 294 | 96.7 | 324 | 92.5 |
Yes | 44 | 3.7 | < 11 | — | < 11 | — | 23 | 7.5 |
Abbreviation: NSCLC, non–small-cell lung cancer
Weighted.
Exact cell sizes < 11 are suppressed to protect patient confidentiality.